Germline vs. somatic BRCA mutations and response to chemotherapy and outcomes in serous ovarian cancer

被引：0

作者：

Chan, J. K. ^{[1
]}

Kiet, T. K. ^{[1
]}

Chen, L. ^{[1
]}

Ruskin, R. ^{[1
]}

Sherman, A. E. ^{[1
]}

Monk, B. J. ^{[2
]}

Kapp, D. S. ^{[3
]}

Krivak, T. C. ^{[4
]}

机构：

[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[2] Creighton Univ, Sch Med, St Josephs Hosp & Med Ctr, Dept Obstet & Gynecol,Div Gynecol Oncol, Phoenix, AZ USA

[3] Stanford Canc Ctr, Dept Radiat Oncol, Stanford, CA USA

[4] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA

来源：

GYNECOLOGIC ONCOLOGY | 2011年 / 123卷 / 02期

关键词：

D O I：

10.1016/j.ygyno.2011.07.055

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：436 / 436

页数：1

共 50 条

[1] Chemotherapy response and survival in serous ovarian cancer patients with BRCA mutations
Chan, J.
Kiet, T.
Chen, L.
Ruskin, R.
Sherman, A.
Lesnock, J.
Monk, B.
Kapp, D.
Krivak, T.
GYNECOLOGIC ONCOLOGY, 2012, 125 : S85 - S85
[2] Chemotherapy response and survival in serous ovarian cancer patients with BRCA mutations
Chan, J. K.
Kiet, T. K.
Chen, L.
Ruskin, R.
Sherman, A. E.
Monk, B. J.
Kapp, D. S.
Krivak, T. C.
GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 435 - 436
[3] BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
Moschetta, M.
George, A.
Kaye, S. B.
Banerjee, S.
ANNALS OF ONCOLOGY, 2016, 27 (08) : 1449 - 1455
[4] Frequency of germline and somatic BRCA1 mutations in ovarian cancer
Berchuck, A
Heron, KA
Carney, ME
Lancaster, JM
Fraser, EG
Vinson, VL
Deffenbaugh, AM
Miron, A
Marks, JR
Futreal, PA
Frank, TS
CLINICAL CANCER RESEARCH, 1998, 4 (10) : 2433 - 2437
[5] Somatic versus germline BRCA mutations screening in ovarian cancer.
Nunes, Hugo S. M.
Machado, Patricia
Fragoso, Sofia
Santos, Sidonia
Silva, Fernanda
Felix, Ana
Luis, Ana
Opiniao, Ana
Clara, Ana
Bento, Sandra
Miranda, Ana
Francisca, Ana
Vaz, Fatima H.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[6] Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer
Foster, KA
Harrington, P
Kerr, J
Russell, P
DiCioccio, RA
Scott, IV
Jacobs, I
ChenevixTrench, G
Ponder, BAJ
Gayther, SA
CANCER RESEARCH, 1996, 56 (16) : 3622 - 3625
[7] Germline versus Somatic BRCA mutations: Analysis of the cancer genome atlas project in patients with advanced stage serous epithelial ovarian cancer
Lesnock, J.
Krivak, T.
Kiet, T.
Sherman, A.
Monk, B.
Ruskin, R.
Kapp, D.
Chen, L.
Chen, J.
GYNECOLOGIC ONCOLOGY, 2012, 125 : S34 - S34
[8] Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer
Morgan, Robert D.
Wang, Xin
Barnes, Bethany M.
Spurgeon, Laura
Carrot, Aurore
Netto, Daniel
Hasan, Jurjees
Mitchell, Claire
Salih, Zena
Desai, Sudha
Shaw, Joseph
Winter-Roach, Brett
Schlecht, Helene
Burghel, George J.
Clamp, Andrew R.
Edmondson, Richard J.
You, Benoit
Evans, D. Gareth R.
Jayson, Gordon C.
Taylor, Stephen S.
BRITISH JOURNAL OF CANCER, 2024, 131 (12) : 1919 - 1927
[9] Association of somatic mutations in BRCA2 BRC domain with chemotherapy sensitivity and survival in high grade serous ovarian cancer
Zhang, Guonan
Zhang, Jie
Zhu, Yi
Liu, Hong
Shi, Yu
Mi, Kun
Li, Meiying
Zhao, Qi
Huang, Ziyi
Huang, Jianming
EXPERIMENTAL CELL RESEARCH, 2021, 406 (01)
[10] Germline and somatic mutations of homologous recombination associated genes in non-serous ovarian cancer
Sugino, Kentaro
Yoshihara, Kosuke
Yamaguchi, Manako
Yachida, Nozomi
Mori, Yutaro
Yamawaki, Kaoru
Suda, Kazuaki
Tamura, Ryo
Ishiguro, Tatsuya
Adachi, Sosuke
Isobe, Masanori
Yamaguchi, Masayuki
Sekine, Masayuki
Kashima, Katsunori
Nakaoka, Hirofumi
Inoue, Ituro
Enomoto, Takayuki
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 121 - 121

← 1 2 3 4 5 →